G6 Materials Corp. Reports Surge in Orders and Provides an Update on COVID-19 Situation
March 17, 2020
TSX-V: GGG, OTCQB: GPHBF
Ronkonkoma, NY USA. – G6 Materials Corp (former Graphene 3D Lab).
“Company” or “G6,” TSX-V: GGG) provides an update to shareholders to outline the changes in the business operations related to the COVID-19 infection outbreak. It includes measures taken to protect our personnel and partners as well as an enhanced interest in our sterilization products. The COVID-19 infection, which we are addressing in a very serious manner, is spreading around the world and affects all of our lives. We have minimized any possible disruptions in our services due to the potential personnel quarantine and interruptions of supply by taking appropriate preventative measures. Non-essential personnel to the operations are encouraged to work from home. We have also temporarily canceled all non-essential travel, including all tradeshows and international destinations. Despite the situation with the infection outbreak, we are committed and able to provide ongoing services to our customers and business partners. The management, anticipating possible delays in supply, has undertaken timely measures to ensure that we have sufficient inventory of raw materials to keep the manufacturing processes uninterrupted. The COVID-19 quarantine has caused the closure of universities and research centers all around the world, which may ultimately lead to a decrease in orders for our scientific products. However, we anticipate that this will be more than compensated by the growth of interest in our healthcare products. We have received a very positive response, including a spike in orders, to our air filtration and sterilization products, that we hope it will help to mitigate the impact of the infection. Our other prior developments continue to stay the course. We look forward to providing an update shortly regarding both our Singapore high-performance composites (original release date June 4, 2019) and Pharma “Process for Synthesizing Triflouroketoes” projects (original release date October 29, 2019). We urge all of our shareholders, and the public in general, to take appropriate precautions. We are committed to providing our customers with the best support through these turbulent times. ON BEHALF OF THE BOARD: Daniel Stolyarov, President & CEO
About G6 Materials Corp.
G6 Materials Corp. is a technology company and world-leader in creating value through the development of innovative graphene-based solutions. The Company is strategically focused on serving the global air filtration and purification market with new products to meet growing demand. G6 also sells a range of graphene-based products and other materials, including but not limited to 3D printing materials, conductive epoxies, fine chemicals, high performance composites and R&D materials, with numerous customers from among the Fortune 500 list of companies, as well as NASA and leading universities. G6 has identified new graphene-based applications to accelerate growth into the future. Accordingly, the Company has a valuable IP portfolio currently comprised of three granted patents, three provisional patents and five patent applications filed. The Company’s management team and employees have a deep understanding of graphene technology based on decades of aggregate academic and commercial experience. Located in Ronkonkoma, New York, its premium research laboratory and scalable production facility is equipped with advanced analytical and material processing equipment. The Company’s e-commerce websites are listed below:
3D printable filaments can be purchased at www.blackmagic3D.com
Adhesive materials distributed under the G6-EpoxyTM trade name and can be purchased at www.g6-epoxy.com
ChemApproach is a worldwide supplier of a wide variety of unique chemical building blocks, which can be found at http://www.chemapproach.com
Graphene Laboratories Inc. currently offers over 100 graphene and related products available at Graphene-Supermarket.com
This news release may contain forward-looking statements. Forward-looking statements are statements that relate to future, not past, events. In this context, forward-looking statements often address a company’s expected future business and financial performance, and often contain words such as “anticipate,” “believe,” “plan”, “estimate”, “expect”, and “intend”, statements that an action or event “may”, “might”, “could”, “should”, or “will” be taken or occur, or other similar expressions. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the following risks: the risks associated with outstanding litigation, if any; risks associated with adoption by industries of graphene-based products health and environmental factors affecting adoption of these technologies; reliance on key personnel; the potential for conflicts of interest among certain officers, directors or promoters with certain other projects; the absence of dividends; competition; dilution; the volatility of our common share price and volume; and tax consequences to U.S. shareholders. Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date that statements are made, and the Company undertakes no obligation to update forward-looking statements if these beliefs, estimates, and opinions or other circumstances should change. Investors are cautioned against attributing undue certainty to forward-looking statements. Albeit the operation of newly suggested products are based on strong scientific evidence, the Company cannot guarantee the performance parameters of the new products and their efficiency against the specific microbes including all types of viruses and bacteria until testing is completed. Further, the Company can not guarantee any outcomes of such testing. Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.
Contact G6 for General Inquiry
Contact our business team, request details on products, or ask a technical question.